by C28H22F3N
Nilotinib Capsules (Tasigna) 0.15g; 0.2g
Nilotinib Capsules
A public medicine summary is being prepared.
Public medicine directory
Antineoplastic and Immunomodulating Agents
Browse public medicine summaries, manufacturers, and approval information for Antineoplastic and Immunomodulating Agents.
1653 medicinesPage 116 of 138
0.2 g (calculated as C23H24FN5
Dabole (Tarextinib Adipate Capsules) 0.2g
Taletrectinib Adipate Capsules
A public medicine summary is being prepared.
0.1g
Gleevec (Imatinib Mesylate Capsules) 0.1g
Imatinib Mesylate Capsules
A public medicine summary is being prepared.
0.1 g
Gleevec (Imatinib Mesylate Tablets) 0.1g
Imatinib Mesylate Tablets